found that GJB2 expression decreased post-chemotherapy compared to pre-chemotherapy and was associated with better survival in breast cancer, suggesting that GJB2 expression correlated with the response to chemotherapy (13). The gene discussed is GJB2; the disease is breast carcinoma.